FDA Press ReleasesOriginal article
FDA Seeks Public Input to Support Ibogaine Research
RegulatoryibogainePositive
AI Analysis
Summary
The FDA announced a request for information seeking public input on approaches for designing early-phase clinical trials of ibogaine drug products, indicating early regulatory engagement with the compound.
Clinical Trial Data
Phase
early-phase
Outcome Details
FDA requesting public input on early-phase clinical trial design approaches for ibogaine drug products
Importance:3/10
Sentiment:
0.30
FDAibogaineclinical trialsregulatorypublic commentdrug development
Read the original article
Published by FDA Press Releases on October 5, 2026 1:02 PM